Komori
Share Issuance and Disposal4572Carna Biosciences,Inc.Pharmaceuticals

Notice of Completion of Payment for the Issuance of New Shares as Restricted Stock to Employees

With respect to the issuance of new shares as restricted stock for employees, which was resolved and disclosed on 16 April 2026, payment and the issuance procedures were completed on 13 May 2026.

Worth reading
44Recurring
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
32300
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares as restricted stock to employees

Who receives how much32,300Shares

32,300 new shares

2 employees of the Company, 32,300 shares

The lower thin line represents the existing number of shares to which these shares will be added.

¥425 per share
Total issue value

¥13,727,500

Categories and Number of Persons Covered
2 employees of the Company, 32,300 shares
Payment date
13 May 2026
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares as restricted stock to employees
Number of shares to be issued or disposed of32,300 new shares
Issue price and disposal price¥425 per share
Total issue value¥13,727,500
Payment date13 May 2026
Intended allottee2 employees of the Company, 32,300 shares
Categories and Number of Persons Covered2 employees of the Company, 32,300 shares
Items this document does not state (21)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Allocation of specified restricted stock to employees. No other reason was stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Completion of Payment for the Issuance of New Shares as Restricted Stock to Employees | Carna Biosciences,Inc. (4572) timely disclosure | Komori